An interventional study of Physical activity in Poly Cystic Ovary Syndrome and Overweight , Obesity, sponsored by University Hospital, Clermont-Ferrand. Not yet recruiting at 1 site in France. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-06-22.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Basic science
The primary objective of this study is to investigate the effects of a multidisciplinary intervention, including a targeted adapted physical activity program, on lipid oxidation during a walking exercise in women with overweight or obesity, with or without polycystic ovary syndrome. Specifically, the study aims to compare changes in lipid oxidation before and after the intervention between women with polycystic ovary syndrome and those without polycystic ovary syndrome.
The secondary objectives are to assess the impact of polycystic ovary syndrome on several physiological and metabolic parameters in women with overweight or obesity. These include: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during a walking exercise; (iv) body composition, glycemic and lipid profiles, and circulating levels of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness.
In addition, the effect of the multidisciplinary intervention, including the adapted physical activity program, will be evaluated on these same outcomes: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during walking exercise; (iv) body composition, glycemic and lipid profiles, and concentrations of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness, in women with overweight or obesity, with or without polycystic ovary syndrome.
3,670 studies on the registry are indexed under Overweight; 850 are open to participants now.
This study's planned enrollment of 40 is below the median of 73 across 3,175 interventional studies indexed under Overweight.
Browse Overweight studies →University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Physical activity
Participants will participate to adapted physical activity, supervised by a professional
Lipid oxidation during walking exercise
Time frame: Baseline and after 10 weeks of intervention
Energy expenditure at rest
Time frame: Baseline and after 10 weeks of intervention
Lipid oxidation at rest
Time frame: Baseline and after 10 weeks of intervention
Carbohydrate oxidation at rest
Time frame: Baseline and after 10 weeks of intervention
Systolic blood pressure at rest
Time frame: Baseline and after 10 weeks of intervention
Diastolic blood pressure at rest
Time frame: Baseline and after 10 weeks of intervention
Heart rate at rest
Time frame: Baseline and after 10 weeks of intervention
Energy expenditure during walking exercise
Time frame: Baseline and after 10 weeks of intervention
Energy cost of walking
Time frame: Baseline and after 10 weeks of intervention
Carbohydrate oxidation during walking exercise
Time frame: Baseline and after 10 weeks of intervention
Heart rate during walking exercise
Time frame: Baseline and after 10 weeks of intervention
Fat mass
Time frame: Baseline and after 10 weeks of intervention
Fat-free mass
Time frame: Baseline and after 10 weeks of intervention
Body hydration
Time frame: Baseline and after 10 weeks of intervention
Fasting glycemia
Time frame: Baseline and after 10 weeks of intervention
Fasting insulin concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting triglyceride concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting LDL cholesterol concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting HDL concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting total cholesterol concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting free-fatty acid concentrations
Time frame: Baseline and after 10 weeks of intervention
Follicle-stimulating hormone concentrations
Time frame: Baseline and after 10 weeks of intervention
Luteinizing hormone concentrations
Time frame: Baseline and after 10 weeks of intervention
Estrogen concentrations
Time frame: Baseline and after 10 weeks of intervention
Progesterone concentrations
Time frame: Baseline and after 10 weeks of intervention
Total testosterone concentrations
Time frame: Baseline and after 10 weeks of intervention
Free testosterone concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting leptin concentrations
Time frame: Baseline and after 10 weeks of intervention
Fasting adiponectin concentrations
Time frame: Baseline and after 10 weeks of intervention
Time spent in sedentary behaviors
Time frame: Baseline and after 10 weeks of intervention
Time spent in moderate-to-vigorous physical activity
Time frame: Baseline and after 10 weeks of intervention
Physical fitness-minute walking distance
Time frame: Baseline and after 10 weeks of intervention
Right hand grip strength
Time frame: Baseline and after 10 weeks of intervention
Left hand grip strength
Time frame: Baseline and after 10 weeks of intervention
Number of repetitions during the 30-seconde chair stand test
Time frame: Baseline and after 10 weeks of intervention
Herat rate at the end of the step test
Time frame: Baseline and after 10 weeks of intervention
Heart rate 1 minute after the end of the step test
Time frame: Baseline and after 10 weeks of intervention
Heart rate 2 minutes after the end of the step test
Time frame: Baseline and after 10 weeks of intervention
Heart rate 3 minutes at the end of the step test
Time frame: Baseline and after 10 weeks of intervention
Plan to share: No — Internal regulation
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand